Ascend (Drug Discovery)

Website
Current Valuation
$150.9M
As of November 12, 2024
Total Funding Raised
$194.3M
Last Round
Early Stage VC

$42.5M

Last Funding
Nov 2024

Funding date

Capital Efficiency
0.78x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Ascend (Drug Discovery) is currently valued at $150.9M as of November 12, 2024. The company has raised a total of $194.3M in funding.

Capital Efficiency

With a capital efficiency ratio of 0.78x, Ascend (Drug Discovery) has achieved a valuation that is 0.78 times the total capital raised.

Track Ascend (Drug Discovery) Valuation Updates

Get notified when Ascend (Drug Discovery) raises new funding or valuation changes

Explore More Data
Detailed analysis for Ascend (Drug Discovery)

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Ascend (Drug Discovery)'s valuation history, funding rounds, and growth metrics.

No credit card required

What is Ascend (Drug Discovery) Worth in 2026?

Ascend (Drug Discovery) is a leading private company in the technology sector. Track Ascend (Drug Discovery)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Ascend (Drug Discovery) Valuation is Determined

Private company valuations like Ascend (Drug Discovery)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.